Personal care major Colgate-Palmolive has developed an antiperspirant formula containing cannabidiol (CBD) that it says works as an anti-irritant on the skin. Writing in its international patent, Colgate-Palmolive said it had developed the antiperspirant in response to a growing need for gentler, anti-irritant antiperspirants and to align with the surging interest in CBD. The formulation had been designed for use in various antiperspirant deodorant forms, including roll-on, stick, gel and even aerosol.
Colgate-Palmolive said whilst there was a wealth of “conventional antiperspirant salts” used by industry, including aluminium and zirconium salts, many could cause skin irritation. And with an estimated 50% of the world population considered to have sensitive skin, it said there was a clear need for an alternative. “It is therefore desirable to develop and formulate efficacious anti-irritant ingredients into personal care products to mitigate potential irritant-induced redness, tingling, itching, or burning of the skin to a tolerable level for improved consumer compliance,” Colgate Palmolive wrote in its patent filing.
By Kacey Culliney – 10 Jun 2021
Kristel Adriaenssens Milet 1 April 2025 Social intelligence company Dynvibe, which specialises in behavioural marketing…
26 March 2025 The 35th IFSCC Congress will take place in Cannes from September 15…
This AI-powered skin diagnostic device uses bio-optical technology alongside AI algorithms to analyze the skin’s…